Norges Bank’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-586,420
Closed -$18.9M 2267
2021
Q3
$18.9M Buy
586,420
+100,434
+21% +$3.24M ﹤0.01% 1521
2021
Q2
$14.9M Sell
485,986
-64,207
-12% -$1.96M ﹤0.01% 1653
2021
Q1
$16.8M Sell
550,193
-181,065
-25% -$5.51M ﹤0.01% 1618
2020
Q4
$14.5M Buy
731,258
+73,900
+11% +$1.46M ﹤0.01% 1664
2020
Q3
$8.57M Sell
657,358
-67,225
-9% -$877K ﹤0.01% 1760
2020
Q2
$8.22M Sell
724,583
-154,894
-18% -$1.76M ﹤0.01% 1770
2020
Q1
$12.6M Sell
879,477
-15,212
-2% -$218K ﹤0.01% 1502
2019
Q4
$24.4M Hold
894,689
0.01% 1420
2019
Q3
$25.6M Sell
894,689
-142,180
-14% -$4.07M 0.01% 1322
2019
Q2
$28.8M Sell
1,036,869
-125,943
-11% -$3.5M 0.01% 1255
2019
Q1
$38.6M Hold
1,162,812
0.01% 1037
2018
Q4
$33.8M Hold
1,162,812
0.01% 1028
2018
Q3
$53.5M Sell
1,162,812
-22,878
-2% -$1.05M 0.02% 819
2018
Q2
$44.3M Sell
1,185,690
-46,639
-4% -$1.74M 0.02% 929
2018
Q1
$36.4M Sell
1,232,329
-78,114
-6% -$2.31M 0.01% 1001
2017
Q4
$45M Sell
1,310,443
-97,289
-7% -$3.34M 0.02% 873
2017
Q3
$50.9M Buy
1,407,732
+91,253
+7% +$3.3M 0.02% 764
2017
Q2
$34M Buy
1,316,479
+53,132
+4% +$1.37M 0.01% 1024
2017
Q1
$24.3M Buy
1,263,347
+404,375
+47% +$7.76M 0.01% 1258
2016
Q4
$14.3M Buy
858,972
+103,927
+14% +$1.73M 0.01% 1510
2016
Q3
$14.8M Buy
755,045
+86,975
+13% +$1.71M 0.01% 1437
2016
Q2
$20.4M Buy
668,070
+114,266
+21% +$3.5M 0.01% 1185
2016
Q1
$20.7M Sell
553,804
-54,068
-9% -$2.02M 0.01% 1137
2015
Q4
$26.2M Hold
607,872
0.01% 979
2015
Q3
$22.8M Buy
607,872
+114,549
+23% +$4.29M 0.01% 1047
2015
Q2
$16.8M Sell
493,323
-189,630
-28% -$6.45M 0.01% 1293
2015
Q1
$24.2M Sell
682,953
-119,612
-15% -$4.23M 0.01% 1099
2014
Q4
$27.3M Buy
802,565
+31,029
+4% +$1.06M 0.01% 1011
2014
Q3
$29.8M Sell
771,536
-535,096
-41% -$20.6M 0.02% 883
2014
Q2
$50.9M Buy
1,306,632
+653,316
+100% +$25.4M 0.01% 1016
2014
Q1
$22.3M Hold
653,316
0.01% 1069
2013
Q4
$13.7M Buy
653,316
+59,549
+10% +$1.25M 0.01% 1381
2013
Q3
$14M Buy
593,767
+182,588
+44% +$4.29M 0.01% 1340
2013
Q2
$11M Buy
+411,179
New +$11M 0.01% 1409